Si-Bone (SIBN) EBITDA Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | 483.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 483.00 |
| Dec 31, 2025 | 702.00 |
| Sep 30, 2025 | 626.00 |
| Jun 30, 2025 | 1,051.00 |
| Mar 31, 2025 | 1,530.00 |
| Dec 31, 2024 | 1,845.00 |
| Sep 30, 2024 | 1,387.00 |
| Jun 30, 2024 | 1,119.00 |
| Mar 31, 2024 | 483.00 |
| Dec 31, 2023 | 642.00 |
| Sep 30, 2023 | 2,380.00 |
| Jun 30, 2023 | 3,899.00 |
| Mar 31, 2023 | 4,489.00 |
| Dec 31, 2022 | 2,293.00 |
| Sep 30, 2022 | 1,828.00 |
| Jun 30, 2022 | -978.00 |
| Mar 31, 2022 | -1,835.00 |
| Dec 31, 2021 | -1,755.00 |
| Sep 30, 2021 | -2,399.00 |
| Jun 30, 2021 | 2,653.00 |
| Mar 31, 2021 | 1,420.00 |
| Dec 31, 2020 | 586.00 |
| Sep 30, 2020 | 2,273.00 |
| Jun 30, 2020 | -3,679.00 |
| Mar 31, 2020 | -1,225.00 |
| Dec 31, 2019 | -1,203.00 |
| Sep 30, 2019 | -3,428.00 |
| Jun 30, 2019 | -2,996.00 |
| Mar 31, 2019 | -2,908.00 |
| Dec 31, 2018 | 174.00 |
| Sep 30, 2018 | 1,302.00 |